Market Cap 88.82B
Revenue (ttm) 403.43B
Net Income (ttm) 4.76B
EPS (ttm) N/A
PE Ratio 18.80
Forward PE 16.63
Profit Margin 1.18%
Debt to Equity Ratio -6.54
Volume 951,600
Avg Vol 902,046
Day's Range N/A - N/A
Shares Out 122.49M
Stochastic %K 11%
Beta 0.35
Analysts Strong Sell
Price Target $987.53

Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business soluti...

Industry: Medical Distribution
Sector: Healthcare
Phone: 972 446 4800
Address:
6555 State Highway 161, Irving, United States
cynicaloptimist
cynicaloptimist May. 11 at 10:04 PM
My early in the year 'safe' play $MCK is down 12%, while virtually all of my high risk specs are kicking butt and taking names. 😆 I ain't complaining.
0 · Reply
MarketBeat
MarketBeat May. 11 at 7:09 PM
https://marketbeat.com/a/8648818/ $MCK McKesson Q4 Earnings Call Highlights
0 · Reply
KingAP
KingAP May. 11 at 6:59 PM
$MCK added
0 · Reply
Carolrr
Carolrr May. 8 at 2:17 PM
$MCK steady defensive leader, buyers respect dips but upside needs fresh flow
0 · Reply
ryan2022
ryan2022 May. 8 at 11:26 AM
$MCK earnings look solid to me. EPS beat, strong FY27 guidance, and that buyback is massive. Thanks Pop!
0 · Reply
Series
Series May. 7 at 8:49 PM
$MCK disappointed. I was hoping for a bounce after earning
1 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 7 at 8:15 PM
$MCK Q4 '26 Earnings Results & Recap • Reported GAAP EPS of $13.78 up 36.98% YoY • Reported revenue of $96.3B up 6.02% YoY • McKesson is establishing Fiscal 2027 Adjusted Earnings per Diluted Share guidance between $43.80 and $44.60, indicating 12% to 14% forecasted growth, while reaffirming long-term Adjusted EPS growth targets of 13% to 16%.
0 · Reply
PanicSeller8
PanicSeller8 May. 7 at 7:54 PM
$MCK Basically been straight down since really good earnings 3 months ago. No idea what to expect today.
0 · Reply
Estimize
Estimize May. 7 at 3:00 PM
$MCK reports after the close, Estimize Consensus +0.05 EPS and +311.08M Revs compared to WS http://www.estimize.com/mck/fq4-2026?utm_conten
0 · Reply
obron
obron May. 7 at 1:42 PM
$MCK This is interesting. RSI is 15 and still no buying interest. Earnings are tonight, and no one seems interested. This smells like earnings were leaked. I'm interested to see what happens tomorrow, but not interested in being invested.
3 · Reply
Latest News on MCK
McKesson price target raised to $1,050 from $1,000 at UBS

2026-05-08T21:36:33.000Z - 4 days ago

McKesson price target raised to $1,050 from $1,000 at UBS


McKesson price target lowered to $941 from $1,010 at Baird

2026-05-08T16:25:42.000Z - 4 days ago

McKesson price target lowered to $941 from $1,010 at Baird


McKesson price target lowered to $900 from $1,000 at BofA

2026-05-08T11:07:19.000Z - 5 days ago

McKesson price target lowered to $900 from $1,000 at BofA


McKesson reports Q4 EPS $11.69, consensus $11.57

2026-05-07T21:36:23.000Z - 5 days ago

McKesson reports Q4 EPS $11.69, consensus $11.57


McKesson sees FY27 EPS $43.80-$44.60, consensus $44.11

2026-05-07T21:31:22.000Z - 5 days ago

McKesson sees FY27 EPS $43.80-$44.60, consensus $44.11


McKesson down 2% at $737 after Q4 results and FY27 guide

2026-05-07T21:30:27.000Z - 5 days ago

McKesson down 2% at $737 after Q4 results and FY27 guide


McKesson Earnings Call Transcript: Q4 2026

May 7, 2026, 4:30 PM EDT - 5 days ago

McKesson Earnings Call Transcript: Q4 2026


McKesson initiated with an Outperform at William Blair

2026-04-28T10:11:21.000Z - 15 days ago

McKesson initiated with an Outperform at William Blair


McKesson price target lowered to $1,000 from $1,012 at UBS

2026-04-22T13:50:02.000Z - 20 days ago

McKesson price target lowered to $1,000 from $1,012 at UBS


McKesson Corporation Declares Quarterly Dividend

Apr 22, 2026, 8:00 AM EDT - 21 days ago

McKesson Corporation Declares Quarterly Dividend


Is McKesson Stock Still A High-Conviction Compounder?

Apr 21, 2026, 12:26 PM EDT - 21 days ago

Is McKesson Stock Still A High-Conviction Compounder?


McKesson to Sell Stake of Medical-Surgical Unit to Apollo

Apr 20, 2026, 8:58 AM EDT - 22 days ago

McKesson to Sell Stake of Medical-Surgical Unit to Apollo

APO


McKesson price target lowered to $1,000 from $1,040 at BofA

2026-04-06T10:50:08.000Z - 5 weeks ago

McKesson price target lowered to $1,000 from $1,040 at BofA


McKesson Transcript: Leerink Global Healthcare Conference 2026

Mar 11, 2026, 10:00 AM EDT - 2 months ago

McKesson Transcript: Leerink Global Healthcare Conference 2026


McKesson price target raised to $1,040 from $970 at BofA

2026-03-06T12:12:09.000Z - 2 months ago

McKesson price target raised to $1,040 from $970 at BofA

COR


McKesson Announces Planned CFO Transition

Mar 5, 2026, 8:10 AM EST - 2 months ago

McKesson Announces Planned CFO Transition


See How Institutional Inflows Make McKesson Fly

Feb 25, 2026, 8:26 AM EST - 2 months ago

See How Institutional Inflows Make McKesson Fly


How McKesson Stock Surged 17% In A Day

Feb 6, 2026, 11:25 AM EST - 3 months ago

How McKesson Stock Surged 17% In A Day


McKesson boosts 2026 profit forecast amid specialty drug growth

Feb 4, 2026, 7:01 PM EST - 3 months ago

McKesson boosts 2026 profit forecast amid specialty drug growth


McKesson Earnings Call Transcript: Q3 2026

Feb 4, 2026, 4:30 PM EST - 3 months ago

McKesson Earnings Call Transcript: Q3 2026


McKesson Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 12:45 PM EST - 4 months ago

McKesson Transcript: 44th Annual J.P. Morgan Healthcare Conference


Final Trades: Lockheed Martin, QXO and McKesson Corporation

Jan 5, 2026, 1:46 PM EST - 4 months ago

Final Trades: Lockheed Martin, QXO and McKesson Corporation

LMT QXO


McKesson Transcript: UBS Global Healthcare Conference 2025

Nov 10, 2025, 9:30 AM EST - 6 months ago

McKesson Transcript: UBS Global Healthcare Conference 2025


McKesson Earnings Call Transcript: Q2 2026

Nov 5, 2025, 4:30 PM EST - 6 months ago

McKesson Earnings Call Transcript: Q2 2026


How to trade the health care break out

Oct 6, 2025, 2:24 PM EDT - 7 months ago

How to trade the health care break out

MRK UNH VEEV XBI XLV


See How McKesson Shares Rise with Money Flows

Oct 1, 2025, 7:28 AM EDT - 8 months ago

See How McKesson Shares Rise with Money Flows


McKesson Transcript: Investor Day 2025

Sep 23, 2025, 9:30 AM EDT - 8 months ago

McKesson Transcript: Investor Day 2025


McKesson Announces New Organizational Structure

Sep 18, 2025, 8:00 AM EDT - 8 months ago

McKesson Announces New Organizational Structure


McKesson Earnings Call Transcript: Q1 2026

Aug 6, 2025, 4:30 PM EDT - 9 months ago

McKesson Earnings Call Transcript: Q1 2026


McKesson to Host Investor Day on September 23, 2025

Jun 11, 2025, 8:00 AM EDT - 1 year ago

McKesson to Host Investor Day on September 23, 2025


McKesson Corporation Completes Acquisition of Core Ventures

Jun 3, 2025, 8:00 AM EDT - 1 year ago

McKesson Corporation Completes Acquisition of Core Ventures


McKesson To Spin-Off Its Medical-Surgical Solutions Business

May 15, 2025, 2:05 PM EDT - 1 year ago

McKesson To Spin-Off Its Medical-Surgical Solutions Business


McKesson Transcript: Bank of America 2025 Healthcare Conference

May 13, 2025, 11:00 AM EDT - 1 year ago

McKesson Transcript: Bank of America 2025 Healthcare Conference


McKesson to Spin Off Medical-Surgical Company

May 8, 2025, 5:40 PM EDT - 1 year ago

McKesson to Spin Off Medical-Surgical Company


McKesson Earnings Call Transcript: Q4 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

McKesson Earnings Call Transcript: Q4 2025


Registration Opens for Annual McKesson ideaShare Conference

Apr 8, 2025, 9:00 AM EDT - 1 year ago

Registration Opens for Annual McKesson ideaShare Conference


3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock

Apr 4, 2025, 3:42 PM EDT - 1 year ago

3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock

COR CVS PM


cynicaloptimist
cynicaloptimist May. 11 at 10:04 PM
My early in the year 'safe' play $MCK is down 12%, while virtually all of my high risk specs are kicking butt and taking names. 😆 I ain't complaining.
0 · Reply
MarketBeat
MarketBeat May. 11 at 7:09 PM
https://marketbeat.com/a/8648818/ $MCK McKesson Q4 Earnings Call Highlights
0 · Reply
KingAP
KingAP May. 11 at 6:59 PM
$MCK added
0 · Reply
Carolrr
Carolrr May. 8 at 2:17 PM
$MCK steady defensive leader, buyers respect dips but upside needs fresh flow
0 · Reply
ryan2022
ryan2022 May. 8 at 11:26 AM
$MCK earnings look solid to me. EPS beat, strong FY27 guidance, and that buyback is massive. Thanks Pop!
0 · Reply
Series
Series May. 7 at 8:49 PM
$MCK disappointed. I was hoping for a bounce after earning
1 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 7 at 8:15 PM
$MCK Q4 '26 Earnings Results & Recap • Reported GAAP EPS of $13.78 up 36.98% YoY • Reported revenue of $96.3B up 6.02% YoY • McKesson is establishing Fiscal 2027 Adjusted Earnings per Diluted Share guidance between $43.80 and $44.60, indicating 12% to 14% forecasted growth, while reaffirming long-term Adjusted EPS growth targets of 13% to 16%.
0 · Reply
PanicSeller8
PanicSeller8 May. 7 at 7:54 PM
$MCK Basically been straight down since really good earnings 3 months ago. No idea what to expect today.
0 · Reply
Estimize
Estimize May. 7 at 3:00 PM
$MCK reports after the close, Estimize Consensus +0.05 EPS and +311.08M Revs compared to WS http://www.estimize.com/mck/fq4-2026?utm_conten
0 · Reply
obron
obron May. 7 at 1:42 PM
$MCK This is interesting. RSI is 15 and still no buying interest. Earnings are tonight, and no one seems interested. This smells like earnings were leaked. I'm interested to see what happens tomorrow, but not interested in being invested.
3 · Reply
sideload
sideload May. 6 at 11:36 PM
1 · Reply
BillionerOfKing
BillionerOfKing May. 6 at 9:31 PM
$MCK Current Stock Price: $742.99 Contracts to trade: $750.0 MCK May 15 2026 Call Entry: $23.00 Exit: $29.23 ROI: 27% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
JasonCO
JasonCO May. 6 at 6:31 PM
$MCK bsck to $4XX.69
0 · Reply
buddyopalosam
buddyopalosam May. 6 at 6:19 PM
$MCK 690 is support area. Not sure it gets there. Buyer if it gets close to 700.
0 · Reply
JPR_Humbled
JPR_Humbled May. 6 at 4:27 PM
$MCK this price action and volume over the last few weeks has looked very bad, falling way lower than i ever expected for this recent decline. Hope this thing turns around and acts as a proper Value/Def stock with constant + cash flow, and always beating EPS. DCF indicates way undervalued, but institutions might be selling & derisking based on possible inside info. Dont understand this stock right now.
1 · Reply
KingAP
KingAP May. 6 at 4:20 PM
$MCK added
0 · Reply
jklly
jklly May. 6 at 2:58 PM
0 · Reply
RenHenInvestments
RenHenInvestments May. 6 at 2:52 PM
$MCK $COR is bringing this down today, they usually trade in sympathy. Although I am buying MCK on this sell-off. $LLY reported an impressive beat and raise, and MCK is likely handling the majority of the volume. Let's not forget $UNH and $CVS are typically good read throughs for MCK as well, both had great earnings. I feel confident with MCK.
3 · Reply
Arcides
Arcides May. 6 at 2:49 PM
$MCK another healthcare trash
0 · Reply
BuyNowUnlimited
BuyNowUnlimited May. 6 at 2:36 PM
$MCK this is supposed to be a safe haven
0 · Reply
bcrider
bcrider May. 6 at 1:43 PM
$MCK any idea why we’re down 5%?
3 · Reply
BuyNowUnlimited
BuyNowUnlimited May. 4 at 3:12 AM
$MCK is this stock struggling cuz of rising oil prices???
1 · Reply